Opioid-induced constipation

Opioid-induced constipation is a common condition in patients treated with opioids, both for chronic pain management and for other therapeutic purposes. Opioids, including morphine, oxymorphone, and fentanyl, act on the central nervous system but can also cause significant gastrointestinal effects. In particular, they slow intestinal motility, leading to difficulty in evacuating stool. Population studies show that opioid-associated constipation affects a significant proportion of patients receiving opioid therapy. This condition can seriously impair quality of life, lead to complications such as intestinal obstruction, and requires a comprehensive approach to diagnosis and treatment.

History of the disease and interesting historical facts

Opioid-induced constipation has been actively studied since the widespread use of opiates in medical practice. Opioids, used since ancient times to relieve pain, became known to mankind due to their analgesic properties. However, already at the end of the 19th century, their side effects were noticed, among which constipation became one of the most problematic. The first mentions of constipation as a side effect of opioids can be found in medical records of the early 20th century, when opiates began to be used as a means to combat various diseases. Studies conducted in the mid-20th century began to reveal a link between opioid use and intestinal dysfunction, in particular, slowing of its motility. In recent decades, with the increase in the number of prescriptions for opioid drugs, the problem of this side effect has again become relevant, which contributed to an in-depth study of the mechanism of action of opioids on the gastrointestinal tract.

Epidemiology

The epidemiology of opioid-associated constipation shows that this condition occurs in a significant number of patients receiving opioid therapy. According to various studies, from 41% to 87% of such patients report problems with constipation. Meta-analyses show that the frequency of constipation reaches 50-80% among patients receiving opioids on a chronic basis. Moreover, opioid-induced constipation can significantly worsen the quality of life of patients, increasing not only physical discomfort but also psychological suffering. In addition, according to the World Health Organization, the high prevalence of chronic pain and the corresponding prescription of opioids in developed countries contributes to the increased diagnosis of this condition. It is important to note that the incidence of constipation and its association with opioids can vary depending on the dosage, type of opioid, and individual patient characteristics, which makes the problem even more challenging to treat.

Genetic predisposition to this disease

Research suggests that genetic predisposition may play a role in the development of opioid-associated constipation. Certain mutations and variations in genes involved in opioid metabolism and intestinal motility regulation may influence a patient’s sensitivity to side effects. The opioid receptor gene OPRM1 and the opioid metabolism gene CYP2D6 are key candidates for study in this area. Research suggests that certain polymorphisms in these genes may predispose to a higher risk of constipation during opioid therapy. However, further research is needed to better understand the genetic mechanisms and their role in opioid-associated constipation in order to develop new approaches to preventing and treating this condition.

Risk factors for the development of this disease

There are multiple risk factors that contribute to the development of opioid-associated constipation. The main ones include:

• Physical factors:
  • Age (older patients are more likely to experience this problem)
  • Gender (women are more likely to suffer from constipation)
  • Presence of concomitant diseases (eg, diabetes, thyroid disease)
• Chemical factors:
  • Type and dosage of opioid (high doses and strong opiates are more difficult)
  • Concomitant use of other drugs (eg, antidepressants, antihistamines)
• Other factors:
  • Insufficient water and fiber intake
  • Lack of physical activity
  • Stress and change in routine

It is important to evaluate these factors both to prevent constipation and to treat it effectively.

Diagnosis of this disease

Diagnosis of opioid-induced constipation begins with a thorough history and symptom assessment. Common symptoms include:

• Infrequent bowel movements (less than three times a week)
• Difficulty passing stool
• Feeling of incomplete bowel evacuation
• Stool compaction

To confirm the diagnosis, various laboratory and instrumental studies can be carried out:

• Laboratory tests:
  • Complete blood count to detect anemia
  • Biochemical blood test to assess liver and kidney function
  • Thyroid hormone tests for suspected hypothyroidism
• Radiological examinations:
  • Abdominal X-ray for diagnosis of obstruction
  • Ultrasound of abdominal organs to detect abnormalities
• Other types of diagnostics:
  • Endoscopic examinations to exclude organic causes of constipation
  • Gastrointestinal motor testing to assess bowel function
• Differential diagnosis:
  • Identification of organic (eg, tumors) and functional causes of constipation (eg, irritable bowel syndrome)
  • Evaluation of comorbidities that may affect bowel function.

A well-structured approach to diagnosis allows us to effectively identify the causes of constipation and develop individual treatment strategies.

Treatment

Treatment of opioid-induced constipation should be comprehensive and individually tailored. Key approaches to therapy include:

• General treatment:
  • Changing your diet to increase fiber and fluid intake
  • Increase physical activity
• Pharmacological treatment:
  • Use of osmotic laxatives (eg, macrogol)
  • Stimulant laxatives (eg, bisacodyl)
  • Special medications for the treatment of opioid-induced constipation, such as naloxegol and prolifate ederopene
• Surgical treatment:
  • Less commonly used, but possible in cases of severe intestinal obstruction or other serious complications
• Other types of treatment:
  • Physiotherapy and biofeedback to improve bowel motility
  • Use of opioid tapering medications under physician supervision

Effective treatment of opioid-induced constipation is important not only to relieve symptoms but also to improve the overall quality of life of patients receiving opioid therapy.

List of medications used to treat this disease

Today, there are many medications that can be used to treat opioid-induced constipation:

• Macrogol
• Lactulose
• Bisacodyl
• Senna
• Naloxegol
• Proliefate is evenropene
• Probiotics to maintain normal intestinal microflora

Each of these drugs has its own indications and contraindications, which implies the need for a thorough assessment by a physician before starting therapy.

Disease monitoring

Monitoring patients with opioid-induced constipation is an important aspect of treatment. Monitoring steps should include:

• Regular assessment of stool frequency and nature
• Evaluation of the effectiveness of the therapy and possible side effects
• Discussing with the patient his condition and identifying dissatisfaction with the current treatment

The prognosis of opioid-induced constipation depends on timely recognition and appropriate intervention. Complications may arise if the patient's condition is not monitored regularly, which may lead to intestinal obstruction or extreme electrolyte depletion due to persistent constipation.

Age-related features of the disease

Opioid-induced constipation may present differently in different age groups. In older patients, the condition is more likely to have a negative impact on quality of life, as they may have multiple chronic diseases and limited physical activity. In children, who may receive opioids for pain management, constipation may also significantly reduce comfort and require a special approach to treatment, often using safer and gentler drugs. In younger patients, the compromise between pain control and constipation prevention can be achieved by carefully individualizing dosages and choosing the right medications.

Questions and Answers

• What is opioid-induced constipation? Opioid-induced constipation is a condition in which a person experiences difficulty passing stool as a result of using opiate medications. Opioids slow down bowel movements, leading to infrequent and difficult bowel movements.
• What are the main symptoms of opioid-induced constipation? The main symptoms include infrequent bowel movements, a feeling of incomplete evacuation, difficulty passing stool, and stool impaction.
• What is the risk of constipation with opioids? According to research, constipation occurs in 41% to 87% patients receiving opioid therapy, and this problem significantly worsens the quality of life.
• How is opioid-induced constipation treated? Treatment includes dietary changes, laxatives, and, in severe cases, surgery. Special medications are also used to relieve constipation caused by opioids.
• What are the best ways to prevent constipation when using opioids? Prevention of constipation includes adequate fluid and fiber intake, regular exercise, and, when needed, early use of laxatives.